These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3125673)

  • 1. Axillary lymph node morphology in women with in situ breast carcinoma. An autopsy study.
    Nielsen M; Christensen L; Jensen J; Thomsen JL; Andersen JA
    Virchows Arch A Pathol Anat Histopathol; 1988; 412(4):347-55. PubMed ID: 3125673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contralateral cancerous breast lesions in women with clinical invasive breast carcinoma.
    Nielsen M; Christensen L; Andersen J
    Cancer; 1986 Mar; 57(5):897-903. PubMed ID: 3002593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between cytotoxicity and prognostically significant histologic changes in lymph nodes from patients with cancer of the breast.
    Check IJ; Cobb M; Hunter RL
    Am J Pathol; 1980 Feb; 98(2):325-38. PubMed ID: 6243870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival with mammary cancer related to the interaction of germinal center hyperplasia and sinus histiocytosis in axillary and internal mammary lymph nodes.
    Hunter RL; Ferguson DJ; Coppleson LW
    Cancer; 1975 Aug; 36(2):528-39. PubMed ID: 168957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.
    Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer in English and Japanese women: prognostic significance of sinus histiocytosis and germinal center hyperplasia in axillary lymph nodes.
    Friedell GH; Millis RR; Sato T; Suchi T; Shikata I; Chaudary MA; Hayward JL
    Breast Cancer Res Treat; 1991 May; 18 Suppl 1():S73-6. PubMed ID: 1873561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
    Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
    Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathology of primary tumors and axillary lymph nodes in British and Japanese women with breast cancer.
    Friedell GH; Soto EA; Kumaoka S; Hirota T; Hayward JL; Bulbrook RD
    Breast Cancer Res Treat; 1983; 3(2):165-9. PubMed ID: 6616075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
    Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
    Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of mast cells in the axillary lymph nodes of breast cancer patients.
    Naik R; Baliga P; Bansal R; Pai M
    J Indian Med Assoc; 1997 Dec; 95(12):606-7. PubMed ID: 9586403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axillary lymph node dissection for T1a breast carcinoma. Is it indicated?
    Silverstein MJ; Gierson ED; Waisman JR; Senofsky GM; Colburn WJ; Gamagami P
    Cancer; 1994 Feb; 73(3):664-7. PubMed ID: 8299088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic analysis of microscopically invasive breast carcinoma.
    Jimenez RE; Visscher DW
    Hum Pathol; 1998 Dec; 29(12):1412-9. PubMed ID: 9865826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years.
    Intra M; Rotmensz N; Veronesi P; Colleoni M; Iodice S; Paganelli G; Viale G; Veronesi U
    Ann Surg; 2008 Feb; 247(2):315-9. PubMed ID: 18216539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
    Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
    JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillary lymph node metastases in patients with occult noninvasive breast carcinoma.
    Rosen PP
    Cancer; 1980 Sep; 46(5):1298-306. PubMed ID: 6260331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive model of axillary lymph node involvement in women with small invasive breast carcinoma: axillary metastases in breast carcinoma.
    Martin C; Cutuli B; Velten M
    Cancer; 2002 Jan; 94(2):314-22. PubMed ID: 11900217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial experience with sentinel node biopsy in breast cancer at the National Cancer Center Hospital East.
    Imoto S; Hasebe T
    Jpn J Clin Oncol; 1999 Jan; 29(1):11-5. PubMed ID: 10073145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Identification of sentinel and axillary node involvement in breast cancer].
    Papa MZ; Bersuk D; Koler M; Klein E; Sareli M; Ben-Ari G
    Harefuah; 1997 Nov; 133(10):428-30, 504, 503. PubMed ID: 9418311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
    Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ
    Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.